Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

239results about How to "Increase coronary blood flow" patented technology

Production method for tea vinegar drink

The invention discloses a production method for a tea vinegar drink, and relates to the technical field of processing of drinks. The tea vinegar drink is mainly prepared from tea, momordica grosvenori, white sugar, mountain spring water and acetic acid bacterium. The production method comprises the following steps: after the momordica grosvenori is smashed, the tea, the momordica grosvenori, the white sugar, the mountain spring water and the acetic acid bacterium are respectively weighed, and the weighed raw materials are placed in a pot and boiled to obtain an extract liquid; an acetic acid bacterium strain accounting for 2-3 percent of the total weight of the raw materials is -inoculated, covered and fermented, the product temperature is controlled to be 16-28 DEG C, and the fermentation lasts 10-25 days; acid adjustment is performed on a fermented and obtained feed liquid, the total acid content of the feed liquid is controlled within a range of 0.3-1 g/100ml, and the soluble solid is controlled within a range of 3-5 percent; the tea vinegar drink is obtained via vacuum and sterile filling after the liquid is sterilized. The invention discloses the tea vinegar drink integrating multiple functions of nutrition and health care, vegetal syrup is used as an acetic acid bacteria culture medium for fermentation, the produced tea vinegar drink contains various spicy substances and nutrient ingredients of the tea, the momordica grosvenori and acetate acid, and is good in flavor and high in quality.
Owner:广西三江县康百氏实业有限公司

Chinese medicinal composition for resisting cardiovascular and cerebrovascular diseases

The invention discloses a Chinese medicine combination for treating cardio-cerebral vascular diseases, which is composed of raw materials with the following parts by weight: 30-50 parts of radix astragali, 20-25 parts of angelica, 15-20 parts of hemlock parsley, 30-50 parts of salvia miltiorrhiza, 15-20 parts of pseudo-ginseng, 15-20 parts of hawkthorn and 20-30 parts of radix puerariae; the Chinese medicine combination of the invention has ingenious compatibility, simple prescription, broad source of raw materials, low price as well as the efficacies of tonifying both qi and blood, balancing yin and yang, activating blood circulation and dissolving stasis; the Chinese medicine combination can soften blood vessels through reducing blood fat and blood viscosity and eliminating blood scales and finally achieve the purposes of smoothing blood circulation and activating cardio-cerebral function; furthermore, the Chinese medicine combination has unique efficacy for resisting atherosclerosis as well as significant curative effect on cardio-cerebral vascular diseases like coronary heart disease, cerebral thrombosis, and the like; the total clinical effective rate can reach over 95% and the Chinese medicine combination can achieve good preventive and health care effect through long-term oral administration and has safe oral administration and no toxicity and side effect.
Owner:谭镒昌

Medicine for treating coronary heart disease

The invention relates to a medicine for treating the coronary heart disease. In the invention, more than 10 natural Chinese herbal medicines such as peach kernel, radix psuedostellariae, astragalus root, snakegourd fruit, tuber pinellia, macrostem onion, dalbergia wood, radix salviae miltiorrhizae, villous anomum, rhizoma ligustici wallichii, red peony root, wild ginger, radix notoginseng, long pepper, saffron crocus and the like are adopted and scientifically and reasonably matched, and the effect of each medicine synergistically acts so as to achieve the purpose of effectively treating the coronary heart disease. The medicine promotes blood circulation, dissolves stasis, invigorates pulse, alleviates pain, is used for treating the coronary heart disease and angina pectoris and eliminates symptoms, such as depression caused by the non-smooth blood flow of people with the coronary heart disease, dismay or palpitation caused by ischemia and the like. The symptoms can be obviously relieved or eliminated after the medicine is taken for about a week, and normally, the symptoms can be cured within about 15 days. The total effective rate is more than 97%, and the cure (acting) rate is more than 84%. The property of the medicine is mild, the medicine is easy to take, no relapse occurs after the medicine is stopped being taken, the medicine has short treatment course, quick acting, high cure rate and no toxic or side effect and is safe and reliable, the source of raw materials is abundant, the manufacturing method is simple, the cost is cheap, and the medicine is a preferred choice for patients with the coronary heart disease.
Owner:翟修祥

Hyperglycemia-hyperlipidemia-hypertension relieving health protection tea and preparation method thereof

The invention relates to hyperglycemia-hyperlipidemia-hypertension relieving health protection tea, and aims to solve the problems that the similar health care products are not obvious in hyperglycemia-hyperlipidemia-hypertension relieving effect and are scarce in raw materials. The hyperglycemia-hyperlipidemia-hypertension relieving health protection tea is prepared through the following steps: adding hawthorn fruits and wolfberry fruits into water, soaking for 10-20 minutes, heating and boiling for 5-10 minutes, and filtering to obtain filtrate; then adding coix seeds and licorice roots into the filtrate, soaking for 10-20 minutes, filtering and drying; finally, mixing the dried mixture with frosted folium mori and dicranostigma leptopodum, and grinding to obtain the hyperglycemia-hyperlipidemia-hypertension relieving health protection tea. The hyperglycemia-hyperlipidemia-hypertension relieving health protection tea is composed by taking traditional Chinese medicine theory as the bases; the components contained in the tea such as flavonoids, phenols, vitamins, carotenes, amino acids, mineral substances and organic acids can balance all nutritional ingredients for the human body; synthetic pharmacodynamic effects of all traditional Chinese medicines can be fully utilized to control or intervene hyperglycemia, hyperlipidemia and hypertension; therefore, the hyperglycemia-hyperlipidemia-hypertension relieving health protection tea has the efficacies of enhancing the body vigor, nursing the health, nourishing the vitality, recovering the langerhans gland function, relieving hyperglycemia, hyperlipidemia and hypertension, and diminishing the inflammation.
Owner:吴星剑

Heart auxiliary device

The invention discloses a heart auxiliary device which comprises an outer shell. The outer shell is formed by bonding and fixing a non-elastic flexible rope on the outer surface of a heart model in a spiral mode, a sealed left air bag is arranged along the outer surface of a left heart chamber of the heart model and located in the outer shell, a sealed right air bag is arranged along the outer surface of a right heart chamber of the heart model and located in the outer shell, buckling rings are arranged on the upper portions of the inner walls, close to the side wall of the left air bag and the side wall of the right air bag, of the outer shell respectively, the upper end of the left air bag and the upper end of the right air bag are fixed on the buckling rings, a lower opening of the left air bag is communicated with a left air inlet pipe, a lower opening of the right air bag is communicated with a right air inlet pipe, the left air inlet pipe and the right air inlet pipe penetrate out of the heart apex at the bottom of the outer shell and extend outwards, and the extending parts of the left air inlet pipe and the right air inlet pipe are communicated with an air source control device. The heart auxiliary device is not in direct contact with blood, anticoagulation is not needed in the application process, a series of blood vessel complications like bleeding, thrombosis, hemolysis and immunoreactions are avoided, the infection rate is reduced, and the heart auxiliary device can be suitable for single-heart-chamber assistance and double-heart-chamber assistance, and is flexible in using method.
Owner:刘超
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products